<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-18896" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Cardiac Cancer</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rodriguez Ziccardi</surname>
            <given-names>Mary</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tariq</surname>
            <given-names>Muhammad Ali</given-names>
          </name>
          <aff>Tower Health</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Limaiem</surname>
            <given-names>Faten</given-names>
          </name>
          <aff>University of Tunis El Manar, Tunis Faculty of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ahmed</surname>
            <given-names>Syed Waqar</given-names>
          </name>
          <aff>Aga Khan University Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mary Rodriguez Ziccardi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muhammad Ali Tariq declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Faten Limaiem declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Syed Waqar Ahmed declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>1</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-18896.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Cardiac tumors are uncommon and can be primary or metastatic. Primary cardiac tumors are rare, and the incidence is from 0.001 to 0.3% by autopsy. They can be classified into three clinicopathological groups: 1. benign congenital tumors, 2. benign acquired tumors, and 3. malignant tumors. Nearly 90% of primary cardiac tumors are benign. This activity reviews the etiology, pathophysiology, presentation, and treatment options of cardiac tumors and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Assess&#x000a0;the different types of cardiac tumors and their etiologies.</p></list-item><list-item><p>Identify&#x000a0;the histopathology of the different types of cardiac tumors.</p></list-item><list-item><p>Evaluate&#x000a0;the evaluation process and diagnostic testing for the assessment of cardiac tumors.</p></list-item><list-item><p>Communicate&#x000a0;the importance of improving care coordination among interprofessional team members to improve patient outcomes affected by cardiac tumors.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18896&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18896">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-18896.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Cardiac tumors are uncommon and can be primary or&#x000a0;metastatic. Primary cardiac tumors are rare, and the incidence is from 0.001 to 0.3% by autopsy.<xref ref-type="bibr" rid="article-18896.r1">[1]</xref>&#x000a0;They can be classified into three clinicopathological groups: 1. benign congenital tumors, 2. benign acquired tumors, and 3. malignant tumors. Nearly 90% of primary&#x000a0;cardiac tumors are benign. Myxoma is the most common primary tumor of the heart, accounting for slightly more than half of all primary cardiac tumors.<xref ref-type="bibr" rid="article-18896.r2">[2]</xref> Malignant cardiac tumors are rare and account for 10% of all primary cardiac neoplasms. They&#x000a0;include sarcomas, especially angiosarcomas. Tumors that metastasize to the heart are much more common than primary cardiac tumors but are rarely surgically excised.</p>
      </sec>
      <sec id="article-18896.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Some cardiac tumors occur in the setting of genetic predispositions or are part of genetic syndromes; this may have implications for genetic counseling and&#x000a0;therapeutic implications for targeted therapies.</p>
        <list list-type="bullet">
          <list-item>
            <p>Cardiac rhabdomyomas correlate with tuberous sclerosis,&#x000a0;an autosomal dominant disorder characterized by the development of hamartomas in multiple organs.<xref ref-type="bibr" rid="article-18896.r3">[3]</xref></p>
          </list-item>
          <list-item>
            <p>Cardiac fibromas may correlate with Gorlin syndrome, an autosomal dominant disorder&#x000a0;characterized by developmental abnormalities and a predisposition to neoplasia.<xref ref-type="bibr" rid="article-18896.r4">[4]</xref></p>
          </list-item>
          <list-item>
            <p>Cardiac&#x000a0;myxomas may be part of the Carney complex, an autosomal dominant syndrome.<xref ref-type="bibr" rid="article-18896.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Histiocytoid&#x000a0;cardiomyopathy sometimes occurs in families, but the exact genetic abnormalities are unknown.<xref ref-type="bibr" rid="article-18896.r6">[6]</xref></p>
          </list-item>
          <list-item>
            <p>The genomic profile of most cardiac undifferentiated sarcomas is like that of pulmonary artery intimal sarcomas with recurrent alterations in MDM2, PDGFRA, and CDKN2A genes.<xref ref-type="bibr" rid="article-18896.r7">[7]</xref></p>
          </list-item>
          <list-item>
            <p>Papillary fibroelastomas&#x000a0;have been reported after cardiac instrumentation and thoracic irradiation.<xref ref-type="bibr" rid="article-18896.r8">[8]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18896.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Primary cardiac tumors are much rarer than secondary malignant lesions, occurring in about 0.001 to 0.3% of autopsies. Almost 90% of primary cardiac tumors excised surgically are benign. Until recently, cardiac myxomas had wide recognition as the most common primary benign cardiac neoplasm of adulthood, representing nearly 80% of benign tumors. Secondary malignant disease of the heart and pericardium is considerably more common than primary cardiac malignant disease; in some estimates, it is 30 to 1000 times more common.&#x000a0;In a random autopsy series, the frequency of metastatic involvement was 0.4%; in patients with confirmed cancer, cardiac involvement can be as high as 20%. Spread to the heart is generally&#x000a0;via direct tumor extension, venous/lymphatic spread, or arterial metastasis. The most common underlying malignant diseases with secondary cardiac involvement are carcinoma of the lung, breast, esophagus, stomach, kidneys, melanoma, lymphoma, and leukemia.</p>
      </sec>
      <sec id="article-18896.s5" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>
<bold>Primary Cardiac Tumors</bold>
</p>
        <p>
<bold>Benign Tumors</bold>
</p>
        <p>1. Myxoma</p>
        <list list-type="bullet">
          <list-item>
            <p>The most common benign tumor in adults. More frequently found in the left atrium (80%), followed by the right atrium and occasionally in the ventricles.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>They characteristically arise&#x000a0;around the interatrial septum&#x000a0;next to the fossa ovalis membrane.</p>
          </list-item>
          <list-item>
            <p>They are more common in women and often appear in the sixth&#x000a0;decade of life.</p>
          </list-item>
          <list-item>
            <p>Most cardiac myxomas are sporadic, but familial cases&#x000a0;have&#x000a0;been described.</p>
          </list-item>
          <list-item>
            <p>Macroscopically,&#x000a0;2 basic gross subtypes have been described: solid and villous. Tumors of the solid type may be globular or elongated, with a smooth, shiny, and sometimes undulant surface. Tumors of the villous type have irregular, often friable papillary surfaces.<xref ref-type="bibr" rid="article-18896.r9">[9]</xref></p>
          </list-item>
          <list-item>
            <p>Histologically, the&#x000a0;1 defining&#x000a0;characteristic&#x000a0;is the presence&#x000a0;of&#x000a0;the so-called myxoma cell (or lepidic cell), a cytologically&#x000a0;bland cell with eosinophilic cytoplasm and an oval&#x000a0;or round nucleus.&#x000a0;These stellate, ovoid, or plump spindle cells may occur singly or in groups. The cells are typically within a myxoid matrix rich in mucopolysaccharides. Large, thick-walled vessels are often present near the stalk or the base of the lesion.</p>
          </list-item>
          <list-item>
            <p>Due to the lack of a strong structure, embolization is common.<xref ref-type="bibr" rid="article-18896.r10">[10]</xref></p>
          </list-item>
        </list>
        <p>2. Lipomas</p>
        <list list-type="bullet">
          <list-item>
            <p>The second most frequent primary cardiac mass. Represent 0.5% of&#x000a0;cardiac tumors</p>
          </list-item>
          <list-item>
            <p>More frequently present in the sub-endocardium&#x000a0;and sub-epicardium&#x000a0;of the left ventricle, right atrium, or interatrial septum<xref ref-type="bibr" rid="article-18896.r11">[11]</xref></p>
          </list-item>
          <list-item>
            <p>Macroscopically, lipomas are yellow, soft, smooth, well-circumscribed, encapsulated solitary masses.</p>
          </list-item>
          <list-item>
            <p>Microscopically,&#x000a0;the tumors consist of&#x000a0;white fat with a fibrous capsule and some fibrous septa; the fat cells have minimal to no atypia.</p>
          </list-item>
          <list-item>
            <p>Lipomas are mostly asymptomatic,&#x000a0;but depending&#x000a0;on their location, they can produce arrhythmias or conduction system disease and heart&#x000a0;failure symptoms.</p>
          </list-item>
        </list>
        <p>3. Papillary fibroelastoma</p>
        <list list-type="bullet">
          <list-item>
            <p>Also known as endocardial papilloma</p>
          </list-item>
          <list-item>
            <p>The most frequent tumor of the valves (75%), with the most common location in the aortic valve followed by the mitral valve</p>
          </list-item>
          <list-item>
            <p>Derived from the endocardial cells, 95% were found in the left-sided chambers</p>
          </list-item>
          <list-item>
            <p>More common in men and diagnosed in the 6th to 7th decade of life</p>
          </list-item>
          <list-item>
            <p>Macroscopically, papillary fibroelastomas often have a round, whitish appearance and soft consistency. When placed in solution, multiple delicate fronds unfurl, giving the tumor a "sea anemone-like" appearance. The tumors range from 2 to 50 mm and are usually attached&#x000a0;to the endocardium by a single stalk.<xref ref-type="bibr" rid="article-18896.r12">[12]</xref><xref ref-type="bibr" rid="article-18896.r13">[13]</xref></p>
          </list-item>
          <list-item>
            <p>Microscopically,&#x000a0;papillary fibroelastomas&#x000a0;have narrow&#x000a0;avascular&#x000a0;papillary fronds&#x000a0;that often exhibit&#x000a0;complex branching&#x000a0;patterns. Histologically, the collagen and elastic fiber&#x000a0;arrangement are reminiscent of the tendinous cords of the atrioventricular valves.</p>
          </list-item>
          <list-item>
            <p>Embolization is common. Valvular insufficiency or obstruction is also present. The typical findings include heart failure symptoms and a new murmur in the physical exam.&#x000a0;</p>
          </list-item>
        </list>
        <p>4.&#x000a0;Rhabdomyomas</p>
        <list list-type="bullet">
          <list-item>
            <p>The most common cardiac tumor in children often occurs before the first year of life.&#x000a0;Over 86% of cardiac&#x000a0;rhabdomyomas&#x000a0;have been reported in association with&#x000a0;tuberous&#x000a0;sclerosis.<xref ref-type="bibr" rid="article-18896.r14">[14]</xref></p>
          </list-item>
          <list-item>
            <p>It can be multiple and most commonly affects the ventricles.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Macroscopically, rhabdomyomas are well-defined, unencapsulated, whitish or grayish&#x000a0;nodular masses that range in size from millimeters to several centimeters.</p>
          </list-item>
          <list-item>
            <p>Microscopically,&#x000a0;rhabdomyomas are well-demarcated nodules of enlarged vacuolated&#x000a0;cells with clear cytoplasm because of&#x000a0;glycogen deposits. A characteristic feature is the so-called spider cell appearance.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Symptoms are secondary to obstruction of the cardiac chambers and conduction system disturbance as heart block or ventricular tachyarrhythmias.<xref ref-type="bibr" rid="article-18896.r15">[15]</xref></p>
          </list-item>
          <list-item>
            <p>Most&#x000a0;of these tumors regress spontaneously after birth, and resection is rarely necessary except in cases of obstruction or arrhythmias.</p>
          </list-item>
        </list>
        <p>5. Fibromas:</p>
        <list list-type="bullet">
          <list-item>
            <p>The second most frequent cardiac tumor was found in childhood, with a slight male predominance.</p>
          </list-item>
          <list-item>
            <p>Are intramural tumors, mostly in the left ventricular septum&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Macroscopically, cardiac fibromas are well-circumscribed, firm, usually solitary white masses grossly resembling fibromatosis or uterine leiomyomas. Their appearance on the cut section is typically whorled.</p>
          </list-item>
          <list-item>
            <p>Microscopically, cardiac fibroma comprises monomorphic fibroblasts that demonstrate&#x000a0;little or no atypia. The margins infiltrate into the cardiac muscle.<xref ref-type="bibr" rid="article-18896.r16">[16]</xref></p>
          </list-item>
          <list-item>
            <p>The signs and symptoms correlate with heart failure symptoms, increasing the risk of ventricular tachyarrhythmias and sudden cardiac death.</p>
          </list-item>
        </list>
        <p>
<bold>Malignant Tumors</bold>
</p>
        <p>
<bold>Cardiac Sarcomas</bold>
</p>
        <p>Angiosarcoma</p>
        <list list-type="bullet">
          <list-item>
            <p>The most common primary malignant tumor with an increasing incidence in the fourth decade of life.</p>
          </list-item>
          <list-item>
            <p>The right atrial chamber is the most frequent location</p>
          </list-item>
          <list-item>
            <p>Macroscopically, angiosarcomas are typically dark brown or black hemorrhagic&#x000a0;masses with infiltrating borders.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Microscopically,&#x000a0; angiosarcoma typically infiltrates cardiac muscle without distinct margins. The vascular channels are irregular, anastomosing, and sinusoidal, with pleomorphic lining cells showing frequent mitotic figures.<xref ref-type="bibr" rid="article-18896.r17">[17]</xref></p>
          </list-item>
          <list-item>
            <p>The prognosis of&#x000a0;patients with angiosarcoma is poor.</p>
          </list-item>
        </list>
        <p>
<bold>Secondary Cardiac Tumors</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Metastatic involvement of the heart is frequent and may come from the direct invasion of the tumor from the mediastinum or hematogenous spread.<xref ref-type="bibr" rid="article-18896.r18">[18]</xref></p>
          </list-item>
          <list-item>
            <p>Suspicion for cardiac metastasis or tumor extension needs clarification in patients with new findings suggestive of heart failure or valvular disease.</p>
          </list-item>
          <list-item>
            <p>Pericardial effusion is&#x000a0;1 of the most common findings in patients with malignancy extending to the heart.</p>
          </list-item>
          <list-item>
            <p>Histologically, the cardiac mass is determined by the underlying malignancy causing the cardiac tumor.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18896.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The clinical symptoms of different cardiac tumors are often non-specific and insidious, which can delay diagnosis and surgical management.&#x000a0;The symptoms may relate to processes in the heart, such as valvular dysfunction, pericardial effusion with tamponade, intracardiac blood flow obstruction, arrhythmia, and congestive heart failure. An increasing proportion of cardiac tumors induce no symptoms and become obvious only as an incidental finding.<xref ref-type="bibr" rid="article-18896.r19">[19]</xref>&#x000a0;The clinical manifestations depend on the tumor's size, anatomical location, growth, and invasiveness.<xref ref-type="bibr" rid="article-18896.r19">[19]</xref></p>
      </sec>
      <sec id="article-18896.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Multiple imaging modalities can be useful in determining mass characteristics and origin. Ultimately, due to the complexity of histological evaluation of cardiac masses, most of these tumors, unless removed, cannot be&#x000a0;diagnosed with certainty. The following imaging techniques are mostly used to determine cardiac masses:</p>
        <p>
<bold>Echocardiogram</bold>
</p>
        <p>EKG is an important imaging technique that is likely to be the&#x000a0;1 that makes the diagnosis of the cardiac tumor. Sensitivity and specificity are as high as 90%. It can be performed easily at the&#x000a0;bedside. If further detail is necessary, the use of a transesophageal echocardiogram can help further determine the cardiac tumor's characteristics and location. This modality can determine the tumor's size, mobility, extension, and relation with neighboring structures. It can also determine dynamics related to the mass, such as obstructions or valvular insufficiency. The use of transesophageal echocardiogram can also increase the visualization of small tumors that are unclear in the transthoracic echocardiogram. Contrast echocardiography is also useful in distinguishing between cardiac tumors and cardiac thrombus. Three-dimensional echocardiography is an additional feature to determine the tumor's dimensions, shape, and structural involvement.</p>
        <p>
<bold>Cardiac MRI</bold>
</p>
        <p>Cardiac MRI is an excellent imaging modality to determine tumor size, location, and adjacent structures to determine an approach for surgical removal. Assessment of T1 and T2 signals can help determine the mass's composition. Using contrast, similar to an echocardiogram, can evaluate the presence of a cardiac thrombus versus a tumor.</p>
        <p>
<bold>CT Scan&#x000a0;</bold>
</p>
        <p>This imaging study is useful for assessing cardiac mass and adjacent structure and can determine the nature of the mass by evaluating the X-ray attenuation.<xref ref-type="bibr" rid="article-18896.r20">[20]</xref>&#x000a0;The calcification of the mass is also visible in this imaging study, and it can also evaluate small masses.</p>
        <p>
<bold>Left Heart Catheterization with Coronary Angiogram</bold>
</p>
        <p>Left cardiac catheterization can help determine the blood supply and adjacent structures to the tumors.<xref ref-type="bibr" rid="article-18896.r21">[21]</xref> The technique can also help determine the invasion of the tumor to the epicardial vessels, and with ventriculography, one can determine the extension of the tumor into the ventricular chamber.&#x000a0;</p>
        <p>
<bold>Biopsy and Histological Evaluation</bold>
</p>
        <p>In vivo, intracardial biopsy is a risky procedure mostly done at high-volume centers with experienced surgeons. Right-sided tumors are more likely to be&#x000a0;biopsied&#x000a0;to determine the histology of the tumor.<xref ref-type="bibr" rid="article-18896.r22">[22]</xref>&#x000a0;Left-sided&#x000a0;tumor biopsy has&#x000a0;more risk for perforation and systemic embolization during the procedure. Imaging-guided biopsy increases the success rate of a biopsy and also provides a good tissue specimen for the determination of histological origin.<xref ref-type="bibr" rid="article-18896.r23">[23]</xref>&#x000a0;Cytology from&#x000a0;the pericardial&#x000a0;fluid can also be used to determine the underlying nature of tumors. Ultimately, surgical resection of the tumor with histological evaluation and fluoroscopy&#x000a0;is used to determine the type of&#x000a0;tumor.</p>
      </sec>
      <sec id="article-18896.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>
<bold>Primary Cardiac Tumors</bold>
</p>
        <p>
<bold>Benign Tumors</bold>
</p>
        <p>
<bold>Myxoma</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Surgical removal of the myxoma is necessary due to the high risk of embolization secondary to the friable structure.</p>
          </list-item>
          <list-item>
            <p>It is important to have margins free of the tumor after the resection to prevent recurrence.<xref ref-type="bibr" rid="article-18896.r24">[24]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Lipomas</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>There is no need to intervene in the absence of symptoms or arrhythmias.</p>
          </list-item>
        </list>
        <p>
<bold>Papillary Fibroelastoma</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Left-sided&#x000a0;papillary&#x000a0;fibroelastomas&#x000a0;should undergo surgical resection in patients with large mobile masses or with evidence of embolization.</p>
          </list-item>
        </list>
        <p>
<bold>Rhabdomyoma</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Most&#x000a0;of these tumors regress spontaneously after birth, and resection is rarely necessary, except in cases of obstruction or arrhythmias.</p>
          </list-item>
        </list>
        <p>
<bold>Fibroma</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Complete surgical resection when is feasible is the recommendation.<xref ref-type="bibr" rid="article-18896.r25">[25]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Cardiac Sarcomas</bold>
</p>
        <p>The majority of sarcomas have an overall poor prognosis; some studies have found an increase in survival rate with complete surgical resection of the sarcoma compared with patients without surgical management. Surgical removal after diagnosis is the recommendation.<xref ref-type="bibr" rid="article-18896.r26">[26]</xref></p>
        <p>
<bold>Secondary Cardiac Tumors</bold>
</p>
        <p>Treatment of the underlying malignancy helps with cardiac invasion, but very&#x000a0;frequently, cardiac invasion or metastasis is a poor prognosis factor. Pericardial effusion is managed via pericardial drainage, and if re-accumulation occurs, one can perform a pericardial window.</p>
      </sec>
      <sec id="article-18896.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Important differential diagnoses of cardiac masses are&#x000a0;other more common findings, such as thrombus or vegetation. In these situations, the clinical scenario is vital to determine the origin of the cardiac mass. Intracardiac or prosthetic devices in the infection setting increase&#x000a0;the suspicion&#x000a0;of vegetation. Heart failure symptoms in patients with underlying malignancy can also be related to cardiotoxicity from chemotherapy, and this requires evaluation before determining possible metastasis or invasion of the primary tumor. Infectious diseases can also produce intracardial and pericardial masses or effusion; microbiological assessment is necessary.</p>
      </sec>
      <sec id="article-18896.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of the different cardiac tumors depends on their nature and mechanical disturbances (obstruction/insufficiency). Primary benign cardiac tumors&#x000a0;have the best prognosis unless multiple embolizations occur, especially when systemic, because this can cause multiple strokes with different neurological involvement and physical limitations. A similar situation occurs when the tumor causes mechanical abnormalities in the conduction system, inducing arrhythmias&#x000a0;that can be life-threatening&#x000a0;or valvular disease-causing&#x000a0;syncope or heart failure symptoms.<xref ref-type="bibr" rid="article-18896.r24">[24]</xref>&#x000a0;Malignant tumors, especially primary tumors, are the ones with the worst overall prognosis. Survival after the first&#x000a0;year of diagnosis is low, especially in the absence of surgical excision.<xref ref-type="bibr" rid="article-18896.r27">[27]</xref>&#x000a0;Secondary cardiac tumors&#x000a0;have a poor prognosis, but mostly because the primary tumor is likely to be advanced with possible&#x000a0;different&#x000a0;areas of metastasis. Also, a mechanical compromise occurs in this scenario.</p>
      </sec>
      <sec id="article-18896.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications due to cardiac tumors are mechanical. Embolization causing strokes is a frequent complication that can present as a stroke, and later, while doing a stroke workup, one can find the cardiac mass. Valvular disease, such as obstruction or insufficiency, is common when the mass is adjacent to the leaflets. Syncope can occur when there is a blood flow obstruction&#x000a0;due to the mass, causing hypoperfusion in the brain and the coronaries and predisposing to tachyarrhythmias. The presence of masses next to the conduction system in the epicardium and myocardium can generate electrical abnormalities such as atrioventricular block, complete heart block, and ventricular tachyarrhythmias. Pericardial involvement and pericardial effusion can cause a hemodynamic disturbance with hypotension, shortness of breath, and even cardiac tamponade.</p>
      </sec>
      <sec id="article-18896.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with the diagnosis of cardiac masses need extensive evaluation to determine the etiology and prevent decompensation. Cardiac masses can be abnormal tissue limited to the heart tissue and, after removal, can prevent mechanical complications.</p>
      </sec>
      <sec id="article-18896.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The presence of a cardiac mass requires an interprofessional approach. The differential is enormous, and the diagnosis and management must be prompt to lower morbidity and mortality. Besides, a cardiologist, a cardiac surgeon, an electrophysiologist, an internist, and an intensivist are essential in patient care. Cardiac nurses provide direct and monitor patients. The overall prognosis depends on the type of&#x000a0;mass and extent of myocardial involvement.</p>
      </sec>
      <sec id="article-18896.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18896&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18896">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/cancer/cardiac-cancer-heart-cancer/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=18896">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/18896/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=18896">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-18896.s15">
        <title>References</title>
        <ref id="article-18896.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nomoto</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tani</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Konda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kitai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ota</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kaji</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Imai</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Okada</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Furukawa</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Primary and metastatic cardiac tumors: echocardiographic diagnosis, treatment and prognosis in a 15-years single center study.</article-title>
            <source>J Cardiothorac Surg</source>
            <year>2017</year>
            <month>Nov</month>
            <day>28</day>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>103</fpage>
            <pub-id pub-id-type="pmid">29183343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18896.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ali</surname>
                <given-names>MU</given-names>
              </name>
              <name>
                <surname>Finkel</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Atrial Myxoma.</article-title>
            <source>N Engl J Med</source>
            <year>2018</year>
            <month>Oct</month>
            <day>18</day>
            <volume>379</volume>
            <issue>16</issue>
            <fpage>e26</fpage>
            <pub-id pub-id-type="pmid">30332570</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18896.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ekmekci</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ozkan</surname>
                <given-names>BO</given-names>
              </name>
              <name>
                <surname>Yildiz</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Kocakaya</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Prenatal diagnosis of fetal cardiac rhabdomyoma associated with tuberous sclerosis: A case report.</article-title>
            <source>Case Rep Womens Health</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>19</volume>
            <fpage>e00070</fpage>
            <pub-id pub-id-type="pmid">30094198</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18896.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ritter</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Granquist</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Iyer</surname>
                <given-names>VR</given-names>
              </name>
              <name>
                <surname>Izumi</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Cardiac Fibroma with Ventricular Tachycardia: An Unusual Clinical Presentation of Nevoid Basal Cell Carcinoma Syndrome.</article-title>
            <source>Mol Syndromol</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>219</fpage>
            <page-range>219-223</page-range>
            <pub-id pub-id-type="pmid">30140199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18896.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ando</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Goto</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Date</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Okada</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Takeda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kasahara</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Recurrence of cardiac myxoma in the right atrium with Carney complex following resection of myxomas in both ventricles.</article-title>
            <source>Gen Thorac Cardiovasc Surg</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>67</volume>
            <issue>10</issue>
            <fpage>891</fpage>
            <page-range>891-893</page-range>
            <pub-id pub-id-type="pmid">30094554</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18896.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rea</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Homfray</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Till</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Roses-Noguer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Buchan</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Wilkinson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wilk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>John</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>McKee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Murday</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Ashworth</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Baksi</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Daubeney</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Prasad</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Barton</surname>
                <given-names>PJR</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Ware</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Histiocytoid cardiomyopathy and microphthalmia with linear skin defects syndrome: phenotypes linked by truncating variants in <italic>NDUFB11</italic>.</article-title>
            <source>Cold Spring Harb Mol Case Stud</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>a001271</fpage>
            <pub-id pub-id-type="pmid">28050600</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18896.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neuville</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Collin</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bruneval</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Parrens</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Thivolet</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gomez-Brouchet</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Terrier</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>de Montpreville</surname>
                <given-names>VT</given-names>
              </name>
              <name>
                <surname>Le Gall</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hostein</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Lagarde</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chibon</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Coindre</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Intimal sarcoma is the most frequent primary cardiac sarcoma: clinicopathologic and molecular retrospective analysis of 100 primary cardiac sarcomas.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>38</volume>
            <issue>4</issue>
            <fpage>461</fpage>
            <page-range>461-9</page-range>
            <pub-id pub-id-type="pmid">24625414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18896.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodrigues</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Ferreira</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Almeida</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Campelo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Maciel</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Pinho</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Cardiac papillary fibroelastoma: Report of a surgical series.</article-title>
            <source>Rev Port Cardiol (Engl Ed)</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>37</volume>
            <issue>12</issue>
            <fpage>981</fpage>
            <page-range>981-986</page-range>
            <pub-id pub-id-type="pmid">30528564</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18896.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pinede</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Duhaut</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Loire</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2001</year>
            <month>May</month>
            <volume>80</volume>
            <issue>3</issue>
            <fpage>159</fpage>
            <page-range>159-72</page-range>
            <pub-id pub-id-type="pmid">11388092</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18896.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yuan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zou</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Risk prediction for emboli and recurrence of primary cardiac myxomas after resection.</article-title>
            <source>J Cardiothorac Surg</source>
            <year>2016</year>
            <month>Feb</month>
            <day>02</day>
            <volume>11</volume>
            <fpage>22</fpage>
            <pub-id pub-id-type="pmid">26832806</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18896.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benvenuti</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Mansur</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Lopes</surname>
                <given-names>DO</given-names>
              </name>
              <name>
                <surname>Campos</surname>
                <given-names>RV</given-names>
              </name>
            </person-group>
            <article-title>Primary lipomatous tumors of the cardiac valves.</article-title>
            <source>South Med J</source>
            <year>1996</year>
            <month>Oct</month>
            <volume>89</volume>
            <issue>10</issue>
            <fpage>1018</fpage>
            <page-range>1018-20</page-range>
            <pub-id pub-id-type="pmid">8865802</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18896.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burke</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tavora</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>The 2015 WHO Classification of Tumors of the Heart and Pericardium.</article-title>
            <source>J Thorac Oncol</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>441</fpage>
            <page-range>441-52</page-range>
            <pub-id pub-id-type="pmid">26725181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18896.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Xiu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Fang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Primary malignant cardiac tumors.</article-title>
            <source>J Cancer Res Clin Oncol</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>140</volume>
            <issue>6</issue>
            <fpage>1047</fpage>
            <page-range>1047-55</page-range>
            <pub-id pub-id-type="pmid">24671225</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18896.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bosi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lintermans</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Pellegrino</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Svaluto-Moreolo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Vliers</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The natural history of cardiac rhabdomyoma with and without tuberous sclerosis.</article-title>
            <source>Acta Paediatr</source>
            <year>1996</year>
            <month>Aug</month>
            <volume>85</volume>
            <issue>8</issue>
            <fpage>928</fpage>
            <page-range>928-31</page-range>
            <pub-id pub-id-type="pmid">8863873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18896.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Basso</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Valente</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Poletti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Casarotto</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Thiene</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Surgical pathology of primary cardiac and pericardial tumors.</article-title>
            <source>Eur J Cardiothorac Surg</source>
            <year>1997</year>
            <month>Nov</month>
            <volume>12</volume>
            <issue>5</issue>
            <fpage>730</fpage>
            <page-range>730-7; discussion 737-8</page-range>
            <pub-id pub-id-type="pmid">9458144</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18896.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pacini</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Careddu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pantaleo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Berretta</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Leone</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Marinelli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gargiulo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Di Bartolomeo</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Primary benign cardiac tumours: long-term results.</article-title>
            <source>Eur J Cardiothorac Surg</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>41</volume>
            <issue>4</issue>
            <fpage>812</fpage>
            <page-range>812-9</page-range>
            <pub-id pub-id-type="pmid">22219403</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18896.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Orlandi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ferlosio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Roselli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chiariello</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Spagnoli</surname>
                <given-names>LG</given-names>
              </name>
            </person-group>
            <article-title>Cardiac sarcomas: an update.</article-title>
            <source>J Thorac Oncol</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>5</volume>
            <issue>9</issue>
            <fpage>1483</fpage>
            <page-range>1483-9</page-range>
            <pub-id pub-id-type="pmid">20651614</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18896.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fred</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>van Dijk</surname>
                <given-names>HA</given-names>
              </name>
            </person-group>
            <article-title>Cardiac Metastases from Malignant Melanoma: The "Charcoal Heart".</article-title>
            <source>Methodist Debakey Cardiovasc J</source>
            <year>2017</year>
            <season>Oct-Dec</season>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>254</fpage>
            <page-range>254-255</page-range>
            <pub-id pub-id-type="pmid">29744020</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18896.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strecker</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>R&#x000f6;sch</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Weyand</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Agaimy</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Primary and metastatic cardiac tumors: imaging characteristics, surgical treatment, and histopathological spectrum: a 10-year-experience at a German heart center.</article-title>
            <source>Cardiovasc Pathol</source>
            <year>2012</year>
            <season>Sep-Oct</season>
            <volume>21</volume>
            <issue>5</issue>
            <fpage>436</fpage>
            <page-range>436-43</page-range>
            <pub-id pub-id-type="pmid">22300501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18896.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bleiweis</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Georgiou</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Brundage</surname>
                <given-names>BH</given-names>
              </name>
            </person-group>
            <article-title>Detection of intracardiac masses by ultrafast computed tomography.</article-title>
            <source>Am J Card Imaging</source>
            <year>1994</year>
            <month>Jan</month>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>63</fpage>
            <page-range>63-8</page-range>
            <pub-id pub-id-type="pmid">8130617</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18896.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Song</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ren</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Unusual Coronary Sinus Tumor in a Pregnant Woman.</article-title>
            <source>Int Heart J</source>
            <year>2017</year>
            <month>Aug</month>
            <day>03</day>
            <volume>58</volume>
            <issue>4</issue>
            <fpage>633</fpage>
            <page-range>633-636</page-range>
            <pub-id pub-id-type="pmid">28690294</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18896.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jain</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Maleszewski</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Stephenson</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Klarich</surname>
                <given-names>KW</given-names>
              </name>
            </person-group>
            <article-title>Current diagnosis and management of cardiac myxomas.</article-title>
            <source>Expert Rev Cardiovasc Ther</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>369</fpage>
            <page-range>369-75</page-range>
            <pub-id pub-id-type="pmid">25797902</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18896.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burazor</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Aviel-Ronen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Imazio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Goitein</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Perelman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shelestovich</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Radovanovic</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kanjuh</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Barshack</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Adler</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment.</article-title>
            <source>BMC Cancer</source>
            <year>2018</year>
            <month>Feb</month>
            <day>20</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>202</fpage>
            <pub-id pub-id-type="pmid">29463229</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18896.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Centofanti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Di Rosa</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Deorsola</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dato</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Patan&#x000e8;</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>La Torre</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Barbato</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Verzini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fortunato</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>di Summa</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Primary cardiac tumors: early and late results of surgical treatment in 91 patients.</article-title>
            <source>Ann Thorac Surg</source>
            <year>1999</year>
            <month>Oct</month>
            <volume>68</volume>
            <issue>4</issue>
            <fpage>1236</fpage>
            <page-range>1236-41</page-range>
            <pub-id pub-id-type="pmid">10543485</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18896.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bruckner</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Reardon</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Benign cardiac tumors: a review.</article-title>
            <source>Methodist Debakey Cardiovasc J</source>
            <year>2010</year>
            <season>Jul-Sep</season>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>20</fpage>
            <page-range>20-6</page-range>
            <pub-id pub-id-type="pmid">20834207</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18896.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hudzik</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Szkodzi&#x00144;ski</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zubelewicz-Szkodzi&#x00144;ska</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>G&#x00105;sior</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Primary sarcoma of the heart.</article-title>
            <source>Pol Arch Intern Med</source>
            <year>2017</year>
            <month>Oct</month>
            <day>31</day>
            <volume>127</volume>
            <issue>10</issue>
            <fpage>694</fpage>
            <page-range>694-695</page-range>
            <pub-id pub-id-type="pmid">29065100</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18896.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Brooks</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Goldblum</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Yoder</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Seethala</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pawel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gorman</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Gorman</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Acker</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Narula</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Primary cardiac sarcomas: a clinicopathologic analysis of a series with follow-up information in 17 patients and emphasis on long-term survival.</article-title>
            <source>Hum Pathol</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>39</volume>
            <issue>9</issue>
            <fpage>1385</fpage>
            <page-range>1385-95</page-range>
            <pub-id pub-id-type="pmid">18602663</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
